Drug Type Biosimilar, Monoclonal antibody |
Synonyms Recombinant chimeric anti-TNFα antibody(Zhejiang Hisun Pharmaceutical Co., Ltd.), 重组人鼠嵌合抗肿瘤坏死因子α单抗 (海正药业), HS-626 + [2] |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (28 Sep 2021), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02598 | - | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ankylosing Spondylitis | CN | 28 Sep 2021 | |
Colitis, Ulcerative | CN | 28 Sep 2021 | |
Pediatric Crohn's Disease | CN | 28 Sep 2021 | |
Psoriasis | CN | 28 Sep 2021 |